CACNA1A and type 2 diabetes mellitus: Similarly, evidence for T2D risk reduction was also observed for angina risk reduction via verapamil as proxied by reduced CACNA1A expression (T2D OR = 0.17, 95% CI = 0.10, 0.29, p = 2.1 x 10−10 [IVW MR association]).